Tauriga Sciences Stock Price, News & Analysis

Tauriga Sciences, Inc. (OTCQB: TAUG) announced an updated blister pack design for its Tauri-Gum™ flavors, which now includes a Halal certification icon and QR code. The redesign reflects improvements made since the launch of the Mint flavor in March 2019. The initiative was prompted by discussions with national retailers, signaling progress in their product launch strategy. Additionally, the company reports strong performance in its E-Commerce segment, especially following the September launch of the Rainbow Deluxe Sampler Pack, expected to drive future growth.

Tauriga Sciences (OTCQB: TAUG) has retained Federal Award Management Registration (FAMR) to bid on potential U.S. Government Contracts from the Department of Defense (DOD). This follows the company being approved as a U.S. Government Vendor. Tauriga is a diversified life sciences company known for its Tauri-Gum™ product line, which includes CBD-infused chewing gums and ongoing biotechnology initiatives like a pharmaceutical-grade gum for nausea and a COVID-19 test development project. The company continues to grow its retail and e-commerce operations.

Tauriga Sciences, Inc. (OTCQB: TAUG) has entered a Strategic Alliance with Think Big, LLC, a social impact company founded by CJ Wallace. This partnership aims to launch co-branded CBD and CBG products, utilizing Think Big’s advocacy for cannabis legalization. Notably, Tauriga is focusing on its Tauri-Gum™ product line, which includes vegan and certified options. The company projects revenues between $500,000 and $1,000,000 for FY 2021. The alliance with Think Big is expected to enhance product development and marketing outreach, aligning with both companies' core values.

Tauriga Sciences (OTCQB: TAUG) has secured $135,000 in Inventory Factoring Capital to support revenue growth and a national product launch. This amount is structured as a non-convertible promissory note with a 10% annual interest rate, and a 6-month grace period before the repayment begins in April 2021. Repayment will occur in 7 equal monthly installments of $21,214.29. Moody Capital acted as the Placement Agent for this transaction, which underlines Tauriga's strategy to bolster its operations while diversifying its product offerings in the life sciences sector.

Tauriga Sciences, Inc. (OTCQB: TAUG) has received official authorization to operate as a U.S. Government Vendor after registration in the System for Award Management (SAM). This allows Tauriga to bid on federal contracts, particularly those from the Department of Defense. The company holds a Commercial & Government Entity (CAGE) Code# 8QXV4, with registration valid until October 1, 2021. Tauriga operates in life sciences, focusing on CBD and CBG-infused products, alongside ongoing biotechnology initiatives aimed at improving health outcomes.

Tauriga Sciences, Inc. (TAUG) reported record E-Commerce sales for its 2nd Fiscal Quarter 2021, substantially exceeding the previous record of $62,864.06 set in the 1st Fiscal Quarter 2021. The company remains confident in its growth prospects, supported by a strong fulfillment infrastructure and substantial inventory levels. Additionally, Tauriga continues to see an increase in re-orders from customers. The company engages in the CBD and CBG edibles market, with its main product line being Tauri-Gum™, and is working on biotechnology initiatives, including a pharmaceutical version for chemotherapy patients and a COVID-19 testing collaboration.

Tauriga Sciences (TAUG) announced the development of a national Direct Store Delivery network to enhance the launch of its flagship product, Tauri-Gum™. This initiative is supported by Mr. Checkout Distributors, promising access to thousands of retail locations. Additionally, the company has entered a significant Joint Venture Partnership with a firm in Los Angeles, details of which will be revealed soon. Tauriga's product line includes CBD and CBG-infused chewing gums, and it continues to explore biotechnology ventures, including a pharmaceutical-grade gum for nausea and a COVID-19 testing collaboration.

Tauriga Sciences, Inc. (OTCQB: TAUG) announced a new vendor agreement with Wawa, Inc., allowing the sale of its Tauri-Gum™ products in over 800 Wawa locations across the East Coast. This agreement highlights Tauriga's expansion in the retail market. Tauri-Gum™ is a proprietary functional chewing gum that is both Kosher certified and Vegan friendly, available in various flavors. The company is also engaged in biotechnology initiatives, including developing a pharmaceutical-grade Tauri-Gum™ for nausea regulation and collaborating on a COVID-19 testing solution.